Concepedia

Stephen D. Smith

SD

Statistics

Publications

79

Citations

4.1K

H-Index

32

Active since

1987

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Cleveland Clinic

University of Washington Medical Center

Seattle Cancer Care Alliance

Stephen D. Smith is an author at Fred Hutch Cancer Center specializing in medicine, immunotherapy, and oncology.

ORCID

Top concepts

Publications per year

1987–2025

79

Publications

79

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 428 citations · Full text

, , +2

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

Caron A. Jacobson, Bradley D. Hunter, Robert Redd et al. · Journal of Clinical Oncology · 2020 · 332 citations · Full text

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

Ariela Noy, Sven de Vos, Catherine Thiéblemont et al. · Blood · 2017 · 283 citations · Full text

NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019

Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2019 · 186 citations · Full text

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

Sarah L. Ondrejka, Raymond Lai, Stephen D. Smith et al. · Haematologica · 2011 · 180 citations · Full text

1–5 of 79